Playback speed
10 seconds
ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/Recurrent NSGCT Patients"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Edmund Waller
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Edmund Waller
113 views
June 29, 2023
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY